技术服务

Services

  1. 首页
  2. 文献引用

BuShenKangShuai tablet reduces atherosclerotic lesion by improving blood lipids metabolism and inhibiting inflammatory response via TLR4 and NF-κB signaling pathway

发布日期：2025/3/23 3:46:16
上一篇：EFFECTS OF ADRIAMYCIN, CISPLATIN, AND 5-FLUOROURACIL ON THE TESTES OF ALBINO RATS 下一篇：Significance of Soluble Endoglin as a Possible Marker of Cardiovascular Disease in Type 2 Diabetic Patients
Engine 新舟生物锐竞店铺 Cloud-Clone Crop. NCBI BlastP-蛋白同源性对比 UnlProt-蛋白信息查询 人源蛋白组织表达特异性查询

Copyright ©2025 ANEWBiosystems      粤公网安备44010602013209     粤ICP备2024331411号-1

技术支持：库价化学